Maynard Um
-
-
-
-
-
-
-
RxSight, Inc. (RXST) Tops Q1 EPS by 12c
-
-
-
-
-
-
-
RxSight (RXST) Reiterated at Neutral by UBS: 'Need More Regular Signs of Come-back'
-
-
-
-
-
-
-
RxSight, Inc. (RXST) Misses Q2 EPS by 10c, provides guidance
-
-
-
-
-
-
-
RxSight (RXST) call put ratio 2.7 calls to 1 put as share price down 38%
-
-
-
-
-
-
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
-
-
-
-
-
-
JPMorgan Double Downgrades RxSight Inc. (RXST) to Underweight
-
-
-
-
-
-
-
RxSight Inc. (RXST) PT Lowered to $28 at Stifel
-
433,581 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

